Modulation of TGF-β Superfamily Signaling for Diverse Applications

The inventive concept leverages the core technology of the original patent to modulate the TGF-β superfamily signaling pathway in various contexts, enabling novel applications in agriculture, biofuel production, dermatology, diagnostics, and tissue engineering.

The original patent disclosed compositions and methods for treating spinal muscular atrophy (SMA) by modulating the TGF-β superfamily signaling pathway. However, the patent's scope was limited to SMA treatment. The inventive concept addresses the need for exploring alternative applications of this core technology, unlocking its potential in diverse industries and fields.

The inventive concept involves the use of recombinant ALK4:ActRIIB heteromultimers to modulate the TGF-β superfamily signaling pathway in various contexts. In agriculture, the heteromultimer is used to improve crop yields by altering plant growth and development. In biofuel production, the heteromultimer increases biofuel production by modulating the TGF-β superfamily signaling pathway in microorganisms. In dermatology, the heteromultimer reduces inflammation and promotes skin health by modulating the TGF-β superfamily signaling pathway in skin cells. In diagnostics, the heteromultimer is used in a biosensor to detect changes in the TGF-β superfamily signaling pathway, enabling disease diagnosis and monitoring. In tissue engineering, the heteromultimer promotes stem cell differentiation and tissue regeneration by modulating the TGF-β superfamily signaling pathway in stem cells.

The inventive concept is novel and non-obvious in its application of the core technology to diverse industries and fields, beyond the original patent's scope of SMA treatment. The inventive step lies in recognizing the potential of the TGF-β superfamily signaling pathway modulation in various contexts and developing specific implementations for each application.

Alternative embodiments of the inventive concept could include the use of different TGF-β superfamily ligands or receptors, or the development of novel recombinant heteromultimers with distinct binding profiles. Variations could also include the application of the inventive concept to other industries, such as veterinary medicine or environmental remediation.

The inventive concept has significant commercial potential in various industries, including agriculture, biofuel production, dermatology, diagnostics, and tissue engineering. The market for these applications is substantial, with potential revenue streams in the billions of dollars.